Cogent Biosciences logo

Cogent Biosciences Share Price (NASDAQ: COGT)

$12.06

0.17

(1.43%)

Live

Last updated on

Check the interactive Cogent Biosciences Stock chart to analyse performance

Cogent Biosciences stock performance

as on August 18, 2025 at 11:46 PM IST

  • Today's Low:$11.84
    Today's High:$12.28

    Day's Volatility :3.58%

  • 52 Weeks Low:$3.72
    52 Weeks High:$12.97

    52 Weeks Volatility :71.32%

Cogent Biosciences Stock Returns

PeriodCogent Biosciences IncSector (Health Care)Index (Russel 2000)
3 Months
138.76%
2.3%
0.0%
6 Months
46.79%
-5.8%
0.0%
1 Year
18.78%
-10.9%
0.0%
3 Years
-21.36%
2.8%
-11.6%

Cogent Biosciences Inc Key Stats

Check Cogent Biosciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$11.89
Open
$11.75
Today's High
$12.28
Today's Low
$11.84
Market Capitalization
$1.7B
Today's Volume
$1.0M
52 Week High
$12.97
52 Week Low
$3.72
Revenue TTM
$0.0
EBITDA
$-297.1M
Earnings Per Share (EPS)
$-2.08
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-107.55%

Stock Returns calculator for Cogent Biosciences Stock including INR - Dollar returns

The Cogent Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cogent Biosciences investment value today

Current value as on today

₹1,24,553

Returns

₹24,553

(+24.55%)

Returns from Cogent Biosciences Stock

₹20,480 (+20.48%)

Dollar Returns*

₹4,073 (+4.07%)

Indian investors sentiment towards Cogent Biosciences Stock

-59%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Search interest for Cogent Biosciences Stock from India on INDmoney has decreased by -59% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Cogent Biosciences Inc

  • Name

    Holdings %

  • FMR Inc

    12.24%

  • Paradigm Biocapital Advisors LP

    6.43%

  • COMMODORE CAPITAL LP

    6.38%

  • Kynam Capital Management, LP

    6.09%

  • BlackRock Inc

    5.86%

  • TCG Crossover Management, LLC

    4.99%

Analyst Recommendation on Cogent Biosciences Stock

Rating
Trend

Buy

    82%Buy

    17%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Cogent Biosciences(by analysts ranked 0 to 5 stars)

Cogent Biosciences Share Price Target

What analysts predicted

Upside of 66.59%

Target:

$20.09

Current:

$12.06

Cogent Biosciences share price target is $20.09, a slight Upside of 66.59% compared to current price of $12.06 as per analysts' prediction.

Cogent Biosciences Stock Insights

  • Price Movement

    In the last 3 months, COGT stock has moved up by 143.6%
  • COGT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.4% return, outperforming this stock by 41.7%
  • COGT vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 100.9% return, outperforming this stock by 122.7%

Cogent Biosciences Technicals Summary

Sell

Neutral

Buy

Cogent Biosciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Cogent Biosciences Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Cogent Biosciences Inc logo
-3.33%
46.79%
18.78%
-21.36%
279.87%
Regeneron Pharmaceuticals, Inc. logo
6.39%
-14.65%
-51.51%
-6.14%
-7.82%
Beone Medicines Ltd logo
10.08%
34.96%
66.94%
83.8%
36.85%
Vertex Pharmaceuticals Incorporated logo
-14.33%
-15.0%
-19.52%
31.35%
45.44%
Alnylam Pharmaceuticals, Inc. logo
40.06%
79.56%
63.55%
107.86%
227.15%

About Cogent Biosciences Inc

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor in Phase 3 trial designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company also develops CGT4859, a reversible and selective fibroblast growth factor receptor 2 inhibitor in Phase 1 trial for patients with documented FGFR mutations, including advanced cholangiocarcinoma. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. Cogent Biosciences, Inc. is headquartered in Waltham, Massachusetts.
Organization
Cogent Biosciences
Employees
205
CEO
Mr. Andrew R. Robbins M.B.A.
Industry
Health Technology

Key Management of Cogent Biosciences Inc

NameTitle
Mr. Andrew R. Robbins M.B.A.
President, CEO & Director
Mr. John L. Green C.A., CPA
CFO & Principal Accounting Officer
Dr. John Edward Robinson Ph.D.
Chief Scientific Officer
Dr. Jessica Sachs M.D.
Chief Medical Officer
Mr. Cole Pinnow
Chief Commercial Officer
Mr. Brad Barnett
Chief Technology Officer
Ms. Christi Waarich
Senior Director of Investor Relations
Mr. Evan D. Kearns J.D.
Chief Legal Officer & Corporate Secretary
Ms. Erin Schellhammer
Chief People Officer
Mr. Dana R. Martin Pharm.D.
Senior VP of Medical Affairs & Chief Patient Officer

Important FAQs about investing in COGT Stock from India :

What is Cogent Biosciences share price today?

Cogent Biosciences share price today is $12.06 as on . Cogent Biosciences share today touched a day high of $12.28 and a low of $11.84.

What is the 52 week high and 52 week low for Cogent Biosciences share?

Cogent Biosciences share touched a 52 week high of $12.97 and a 52 week low of $3.72. Cogent Biosciences stock price today, is trending at $12.06, lower by 7.02% versus the 52 week high.

How to invest in Cogent Biosciences Stock (COGT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cogent Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cogent Biosciences Shares that will get you 0.1244 shares as per Cogent Biosciences share price of $12.06 per share as on August 18, 2025 at 11:46 PM IST.

What is the minimum amount required to buy Cogent Biosciences Stock (COGT) from India?

Indian investors can start investing in Cogent Biosciences (COGT) shares with as little as ₹87.3775 or $1 (as of August 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹873.77 in Cogent Biosciences stock (as per the Rupee-Dollar exchange rate as on August 18, 2025). Based on Cogent Biosciences share’s latest price of $12.06 as on August 18, 2025 at 11:46 PM IST, you will get 0.8292 shares of Cogent Biosciences. Learn more about fractional shares .

What are the returns that Cogent Biosciences has given to Indian investors in the last 5 years?

Cogent Biosciences stock has given 279.87% share price returns and 16.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?